Andrea Iannucci, PharmD, BCOP
Assistant Chief Pharmacist, Oncology and
Investigational Drugs Services, UC Davis Health
Health Sciences Clinical Professor
UCSF School of Pharmacy and UC Davis School of Medicine
Cody Angermann, PharmD
Yumena Kawasaki, PharmD
Stepfanie Lam, PharmD
Hanna Yakubi, PharmD
The Oncology Pharmacy Specialty Residency at the University of California, Davis Medical Center, is a one-year, PGY2 specialty residency in Oncology Pharmacy Practice. The residency is supported by the Department of Pharmacy.
Oncology is a strong, well-established and progressive center of excellence at UC Davis Health. The UC Davis Cancer Center is a Comprehensive Cancer Center, as designated by the National Cancer Institute. Clinical Pharmacy Services at UC Davis Health are provided in the areas of medical oncology, hematology, cellular therapy, pediatric oncology, investigational drugs service and at the UC Davis Comprehensive Cancer Center Infusion Rooms and clinics. The oncology specialty residency will provide residents with a comprehensive training and educational experience in oncology pharmacy.
UC Davis Health Pharmacy's mission is to provide the highest quality and most cost-effective pharmaceutical care in an environment that fosters efficient patient-focused care, education and research. Pharmaceutical care services are designed to meet the needs of our customers (primarily patients, nurses and physicians) in a way that constructively impacts all aspects of the medication use process (assessing, prescribing, dispensing, administering and monitoring). We will be flexible and proactive in our responsiveness to opportunities and challenges in the dynamic health-care field.
PGY2 pharmacy residency programs build on Doctor of Pharmacy (PharmD) education and PGY1 pharmacy residency programs to contribute to the development of clinical pharmacists in specialized areas of practice. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Residents who successfully complete an accredited PGY2 pharmacy residency are prepared for advanced patient care, academic, or other specialized positions, along with board certification, if available.
The aim of the UC Davis PGY2 Oncology Pharmacy Residency is to train oncology pharmacists to provide high quality, cost-effective, specialty care to patients with cancer and hematologic disorders in a positive learning environment that promotes independent, critical thinking, creativity and a culture of mutual respect.
The major area of focus is adult Medical Oncology, with an emphasis on supportive care, antineoplastic drug pharmacology, management of patients with malignant and hematologic disorders, investigational cancer therapies, prevention and management of antineoplastic drug toxicities and medication safety in oncology pharmacy practice. Oncology patient care is provided in multidisciplinary settings, and oncology pharmacy residents will interact with clinical pharmacists, pharmacy technicians, physicians, nurses, discharge planners, dietitians, patients, and caregivers to provide comprehensive care to patients with cancer. Daily activities will include coordinating cancer treatment plans, chemotherapy preparation and administration activities, preventive and supportive management of cancer treatment-related complications, providing drug information to physicians, nurses and patients, medication reconciliation and coordination of home and discharge medications.
The UC Davis Health PGY2 Oncology Residency is designed to meet the educational goals and objectives, as outlined by the ASHP PGY2 Oncology Residency Accreditation Standard
The PGY2 Oncology Residency is a full-time, one-year commitment, typically beginning on July 1 and ending on June 30. Clearance to start work by UC Davis Health Employee Health and a Human Resources orientation meeting must be completed prior to the established residency start date.
UC Davis Health PGY2 Oncology Residency Learning Experiences:
The residency learning experiences will primarily be divided into block rotations and longitudinal learning experiences. The majority of rotations will be 4 weeks in duration. Rotation schedules will be determined based on availability and resident interests. Rotation schedules will be adjusted and updated with the resident at each quarterlydevelopment plan meeting.
Required Learning Experiences
Type of Experience
|Orientation to UC Davis Medical Center and PGY2 Oncology residency program. Preparation and training for weekend Oncology Service Coverage.
|Clinical rotation with the inpatient medical oncology service.
|Stem Cell Transplant
|Clinical rotation the stem cell transplant team. Includes inpatient service and weekly SCT clinic.
|Ambulatory Oncology/Infusion 1
|Ambulatory Oncology/Infusion 1 will focus on the fundamentals of the Infusion Pharmacy workflow, with an emphasis on oversight of preparation and dispensing of chemotherapy and investigational drugs and a therapeutic focus in melanoma, GI and GU malignancies.
|Ambulatory Oncology/Infusion 2
|Ambulatory Oncology/Infusion 2 will focus on the coordination of activities in the Infusion Pharmacy. The emphasis will be focused on management of patients with breast cancer, sarcomas, GYN/ONC and thoracic malignancies.
|Provides overview of processes related to dispensing and managing investigational drugs.
|Oncology Specialty Pharmacy 1
|Provides focused learning in the management of patients on oral cancer-directed therapies. Provides the PGY2 Oncology resident with the opportunity to interact with patients, nurses and physicians in the initiation, procurement, assessment, management and follow-up of patients on oral cancer treatment regimens.
|Oncology Specialty Pharmacy 2
|Provides residents additional exposure to the focused oversight of management of patients on oral anti-cancer agents.
|Weekend Oncology Service Coverage
|Alongside a residency preceptor, the oncology resident will provide coverage to the inpatient/ infusion oncology services as part of the ~1:3 weekend rotation.
|Case Conference: Oncology Content/Patient Cases
|Weekly case conference for discussion of content and patient cases as outlined in the ASHP PGY2 Oncology Residency Goals and Objectives Oncology Appendix. Progress will be documented on the content and patient tracker.
|Oncology Pharmacy Practice Management
|Longitudinal learning experiences that captures many of the global and regulatory objectives of the PGY2 Oncology Residency training program, including medication management, compliance with USP and BOP requirements for handling hazardous drugs, oversight of learners and clinical teaching responsibilities. Includes 4 weeks of concentrated learning with Oncology Management Team.
|Oncology Research Project
|Identification and completion of a research project in the area of oncology.
|Elective Learning Experiences
Type of Experience
|Clinical rotation focused on non-malignant hematologic disorders. Includes outpatient hemophilia, sickle cell and MDS clinics; inpatient specialty anticoagulation service.
|Repeat or extension of any of the required learning experiences
|The resident may choose to extend or repeat any of the required learning experiences, based on their interests.
|The BEACON LE offers the resident focused time working with the oncology pharmacy and IDSCC teams in developing new BEACON regimens, reviewing content for accuracy, providing documentation for content development from primary literature or an investigational protocol and validation of the regimen prior to implementation.
|Specialized experience in pain/palliative care. The resident will round with the inpatient Palliative Care Service to provide recommendations on pain management and palliative and supportive care to hospital inpatients.
|Specialized experience in nutrition support and parenteral nutrition. The resident will work with nutrition support pharmacy specialist and hospital dietitians to evaluate patients’ nutritional status and provide recommendations for nutrition support.
|Clinical rotation with the Pediatric Hematology/Oncology services.
|This experience may also be overlapped with a resident’s second SCT rotation. The resident will round with the ID and/or the Transplant ID service to obtain specialty experience in infectious diseases in transplant patients.
Case Conference/ Topic Content:
The UC Davis Health PGY2 Oncology Residency is designed to provide the resident with a broad range of experiences in a variety of practice settings. Required learning experiences have been designed to meet the content requirements, as outlined in the ASHP PGY2 Oncology Residency Accreditation Standard. A content checklist and patient tracker is provided to each resident to document exposure to the required content and patient experiences. Residents will also maintain a list of patients tracked in the UCDH electronic medical record to maintain PHI. This activity will be documented in PharmAcademic as a longitudinal learning experience and progress will be reviewed quarterly with each resident as part of their individual development plans.
UC Davis Health PGY2 Oncology Resident’s Role in Teaching:
UC Davis Health offers many opportunities for both clinical and didactic teaching. The resident will be responsible for assisting preceptors with clerkship teaching for University of California, San Francisco pharmacy students and UC Davis Medical Center PGY1 pharmacy residents during various learning experiences.
The resident will be required to prepare an ACPE accredited pharmacy grand rounds presentation on an oncology topic, based on the resident’s interests and a department needs assessment. The PGY2 Oncology Resident will also have the opportunity to participate in and lead didactic teaching as well as journal club discussions with the other student and resident learners.
Residency Research Project:
All UC Davis Health PGY2 residents are required to complete a research project during their residency and present their research at a regional, state or national conference. In preparation for conducting their research project, the resident will be complete UC Davis Health IRB-required training and certification. The resident will prepare a project proposal, which will be reviewed and approved by the UC Davis Health Pharmacy Research Oversight Committee. The resident will also submit their project to the Pharmacy and Therapeutics Committee and the IRB for approval, before embarking on their research. The resident will also be provided opportunities to present their research at one or more regional pharmacy residency conferences and submit their project as a poster presentation at a national pharmacy meeting (e.g. HOPA). Upon completion of the project, the resident will be required to summarize their research project in a manuscript suitable for submission to a journal for publication.
Pharmacy and Therapeutics Committee Activity:
The PGY2 Oncology resident will be required to participate in the Oncology Sub-Committee of the UC Davis Health Pharmacy and Therapeutics Committee. The resident will also be required to complete the following activities for Oncology Sub-Committee:
Additional assignments will be determined by the RPD in collaboration with the UC Davis Health P&T Committee coordinator, based on the resident’s interests, and the needs of the committee.
The PGY2 Resident is required to prepare a Grand Rounds presentation on an oncology/hematology-related topic for the Department of Pharmacy staff.
The PGY2 Oncology residents will rotate in quarterly assignments on the following UC Davis Health Committees: 1) Oncology Sub-Committee 2) BMT CQI Committee 3) UC Oncology Collaborative Committee 4) Oncology Value Enhancement Committee. The resident will be assigned various activities during each committee rotation. Activities may include specific projects, coordinating agendas and minutes, reviewing documents and maintaining/updating the UC Davis Health Hazardous Drugs Inventory. The purpose of the resident’s committee involvement is to ensure the resident gains exposure to the oncology pharmacist’s role in activities related to quality-improvement, medication safety, safe handling of hazardous drugs, guideline development and assessment/implementation of technology and automation within the institution and pharmacy department.
The PGY2 oncology resident is encouraged to maintain an active role in pharmacy and oncology professional organizations. The resident is strongly encouraged to become a member of the Hematology Oncology Pharmacists Association (HOPA) and attend their annual meeting in the early Spring. The resident will be provided with some financial support from the institution and professional leave time to facilitate participation in professional development activities.
Pharmacy Department Service:
The PGY2 oncology resident will be expected to provide ~400 hours of pharmacy department service. This expectation will be met primarily by providing oncology pharmacist coverage every third weekend plus one major holiday (Thanksgiving, Christmas Eve, Christmas Day or New Year’s Day), at least one minor holiday and ~15 shifts of evening Oncology support. A back-up oncology pharmacist will always be available on site or on-call, to advise and support the PGY2 Oncology resident as needed.
Residents function as licensed pharmacists in patient care activities. As such, minimum knowledge in a variety of areas must be assured. Within one month of starting the Residency, the resident must complete competencies required of all clinical pharmacists. Additionally, if the resident does not already have BLS certification, successful achievement of BLS certification will be required.
Each resident must maintain a portfolio containing all information from the residency year including but not limited to: copies of papers or projects done during rotations, lectures given, research project manuscript, P&T drug monograph, and MUE. The portfolio shall be maintained in Pharm Academic and/or in the resident’s folder on the Pharmacy Department shared drive.
$59,500 annual salary. (Note that this salary includes a stipend for meeting registration, accommodations and travel for one professional meeting.)
Health, Dental and Vision insurance for resident and dependents; vacation, sick leave and professional leave, as outlined in the Pharmacy Resident Manual. . Travel funds (~$2500) are included in the base salary. There is a stipend for Pharmacy Department scrubs.
Resident Personnel Policies:
The following policies can be located in the Pharmacy Resident Personnel Manual
Criteria for Successful Completion of the PGY2 Oncology Residency
Pharmacy Residency training programs at UC Davis Health are conducted under the licensed entity within UC Davis Health which is UC Davis Medical Center.
|(Creating) Design or redesign safe and effective patient-centered therapeutic chemotherapy and supportive care regimens and monitoring plans (care plans) for oncology patients.
|Provide 3 de-identified notes that document direct patient care activities appropriately in the medical record (or where appropriate). The notes provided should be a representative sample of both care plans and other notes that reflect the breadth of resident documentation in the medical record.
|(Applying) For oncology patients, document direct patient care activities appropriately in the medical record or where appropriate.
|(Creating) Prepare or revise a drug class review, monograph, treatment guideline, policy, or protocol related to care of oncology patients.
|- Oncology/supportive medication drug monograph (presented at Oncology Sub-Committee)
- Oncology MUE or Guideline update
|(Analyzing) Identify opportunities for improvement of the medication-use system related to care for oncology patients.
|Provide one example of follow-up and corrective action for medication-use issue (e.g. RL solutions follow-up; risk/hazard mitigation)
|(Creating) Effectively develop and present, orally and in writing, a final project report suitable for publication related to care for oncology patients or for a topic for advancing the pharmacy profession or oncology pharmacy at a local, regional, or national conference.
|- Presentation of research project at a regional, state or national conference
- Complete written manuscript or research project or MUE, suitable for submission for publication
|(Applying) Contribute to oncology departmental management.
|Examples of resident contribution to oncology departmental management, if applicable. - Participation in schedule development
- Participate in recruitment efforts
- Participate in Oncology team meetings
- Policy/procedure review/updates
|(Applying) Design effective educational activities related to care of oncology patients.
|Examples of presentation slides and handouts developed by the resident. It should be clear who the presenter, date, and audience is for each presentation.
- Case conference
- Grand rounds
- Journal clubs
|(Applying) Use effective written communication to disseminate knowledge related to oncology pharmacy.
|Examples of resident written communication to disseminate knowledge (such as newsletters, written drug information, presentations) developed by resident.
- Patient education
|(Applying) Appropriately assess effectiveness of education related to care of oncology patients.
|Examples of assessment of effectiveness of resident presentation/education.
- Pre/Post questions
- Kahoot data
|(Creating) Prepare and implement investigational medication sheets or documents and order templates for an assigned clinical research study.
|Examples of resident preparation and implementation of investigational medication sheets or documents and order templates.
- BEACON orders
- EPIC entries
- Protocols set up